With Bristol Myers Squibb (BMS) now rolling out the SC version of rival nivolumab (Opdivo Qvantig), the shift from 30-minute intravenous (IV) infusion to 5-minute SC injection could be one of the most ...
Subcutaneous ocrelizumab (SC OCR) maintains a safety profile similar to intravenous administration in multiple sclerosis patients. A 920 mg SC OCR dose was identified as optimal, with mild to moderate ...
The NBC Bay Area Investigative Unit traveled to Canada to get a firsthand look at supervised injection sites, which supporters say have helped reduce overdose deaths and the number of used syringes ...
Attendees sit in group sessions to discussion questions and concerns amongst themselves on safe injection sites at South Philadelphia Library (Eric Marsh/WHYY) From Philly and the Pa. suburbs to South ...